Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$136

Avg closing price
Price range

2 Stanley Druckenmiller Sarepta Therapeutics Trades

Stanley Druckenmiller started to build up the position in Sarepta Therapeutics in Q2 2020. Since then they sold 169 Thousand shares. The investor sold all their shares in Q3 2020 and doesn't own any shares in Sarepta Therapeutics anymore.

Avg closing price
Price range
Sold -169 Thousand shares Q3 2020
Avg closing price $151.97
Price range $127.12 - $172.34
New holding (+169 Thousand shares) Q2 2020
Avg closing price $136.08
Price range $93.00 - $171.70

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!